<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increases the generation of plasma 8-epi-<z:chebi fb="11" ids="26333">prostaglandin</z:chebi> F2 (<z:chebi fb="0" ids="34505">8-epi-PGF2alpha</z:chebi>) isoprostane, a sensitive direct marker of in vivo free radical oxidative damage to membrane <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 21 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> underwent an oral 75-g <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma <z:chebi fb="0" ids="34505">8-epi-PGF2alpha</z:chebi> isoprostane concentrations (by gas chromatography [GC]/mass spectrometry [MS]), intralymphocyte reduced-to-oxidized <z:chebi fb="0" ids="16856">glutathione</z:chebi> ratios, and plasma total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity were measured at baseline and 90 min after <z:chebi fb="105" ids="17234">glucose</z:chebi> loading </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Plasma <z:chebi fb="0" ids="34505">8-epi-PGF2alpha</z:chebi> isoprostane concentrations rose significantly (P=0 </plain></SENT>
<SENT sid="4" pm="."><plain>010) from 0.241 +/- 0.1 to 0.326 +/- 0.17 ng/l after 90 min </plain></SENT>
<SENT sid="5" pm="."><plain>Intracellular oxidative balance and plasma <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity did not change in either group </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Plasma concentrations of <z:chebi fb="0" ids="34505">8-epi-PGF2alpha</z:chebi> isoprostane increase during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, providing direct evidence of free radical-mediated oxidative damage and demonstrating a pathway for an association between <z:hpo ids='HP_0011009'>acute</z:hpo> rather than fasting <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and macrovascular risk in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>